Call for Your FREE Evaluation (877) 503-1595

JOHNSON & JOHNSON TRIES TO ADDRESS CRITICAL DRUG SHORTAGE

Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595

Doxil

JOHNSON & JOHNSON TRIES TO ADDRESS CRITICAL DRUG SHORTAGE

Since 2010, ovarian cancer patients have been missing an effective and palatable chemotherapy drug called Doxil.  In 2010, FDA inspectors came upon contamination problems at the Ohio plant, and since then the drug has been in severe shortage.  About 7000 patients a year have used this drug, but by November of 2010, the only factory…..

Posted in Pharmaceutical and Medical Device News,
Tagged Doxil, FDA, J & J, Johnson & Johnson, Overian Cancer,